This page collects WhisperX intelligence signals tagged #GCP. It is designed for humans, search engines, and AI agents: each item links to a canonical source-backed record with sector, source, timestamp, credibility, and exportable structured data.
A security vulnerability has been identified in OpenBao, an open-source secrets management and encryption tool. The vulnerability, tracked as GO-2025-4156, is a Privileged Operator Identity Group Root Escalation flaw present in the `github.com/openbao/openbao` module. The issue affects versions before v2.4.4. The vulne...
A high-severity security vulnerability has been identified in the end-to-end (E2E) test scripts for major cloud platforms, where SSH connections are configured to completely disable host key verification. This flaw, present in scripts for Google Cloud Platform (GCP) and Amazon Web Services (AWS), exposes automated test...
A high-severity command injection vulnerability has been identified within a core Google Cloud Platform (GCP) driver script. The flaw resides in the `_gcp_exec_long` function in the file `sh/e2e/lib/clouds/gcp.sh`, where a critical oversight in command construction could allow an attacker to execute arbitrary shell com...
OpenClaw CLI 工具的核心 GCP 模块中，一个关键的安全函数被发现存在严重的命令注入漏洞。该漏洞位于 `packages/cli/src/gcp/gcp.ts` 文件的 `allowOpenClawPreviewOrigin()` 函数中，被标记为 CRITICAL 级别。其本质与之前报告的 #3215 号问题（Daytona 提供商漏洞）相同，均涉及通过 Node.js 的 `-e` 参数执行动态拼接的 JavaScript 代码。攻击者可能通过构造特定的预览 URL 参数，注入恶意命令，从而在运行该 CLI 工具的系统上执行任意代码。 具体漏洞代码位于第 1075 至 1097 行。该函数旨在将预览 URL 的源地...
A critical security vulnerability has been patched in a GitHub Actions workflow for Google Cloud Platform (GCP) security audits. The workflow, `gcp-security-audit.yml`, was found referencing four key Actions using mutable major version tags (`@v6`, `@v2`, `@v8`), a practice that exposes the entire CI/CD pipeline to tag...
식품의약품안전처가 한국릴리의 항암제 '인루리오정' 품목허가와 관련된 임상시험에 대해 의뢰자와 국내·외 시험기관을 동시에 집중 점검한 결과, 중대한 위반은 발견되지 않았지만 전반적인 절차 보완 필요사항이 확인됐다. 이번 점검은 단순한 규정 위반 여부를 넘어, 품질관리, 모니터링, 기록관리 등 임상시험 전 과정에 걸친 '기본 준수' 수준 자체를 재점검하는 지적이 이어지며 시작됐다. 점검 대상은 한국릴리가 품목허가를 신청한 항암제 '인루리오정200밀리그램(임루네스트란트토실산염)'과 관련된 임상시험이었다. 식약처는 의약품안전나라 등을 통해 이번 점검 결과를 공개하며, 국내...